57664-745 : Repaglinide 1 mg Oral Tablet


NDC: 57664-745
Labeler: Caraco Pharmaceutical Laboratories, Ltd.
Product Type: Human Prescription Drug
Drug Name:  Repaglinide
Dosage Form: Oral Tablet
Application #: ANDA077571
Rev. Date: 


Appearance:


Markings: 745;C
Shapes:  Round
Colors:  Yellow
Size (mm): 6
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

745 C: (57664-745) Repaglinide 1 mg Oral Tablet by Caraco Pharmaceutical Laboratories, Ltd.
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 57664-745-13: 500 TABLET IN 1 BOTTLE (57664‑745‑13)
  • 57664-745-18: 1000 TABLET IN 1 BOTTLE (57664‑745‑18)
  • 57664-745-88: 100 TABLET IN 1 BOTTLE (57664‑745‑88)

Active Ingredients:

  • Repaglinide

Dosage Strength:

  • 1 mg

Inactive Ingredients:

  • Calcium Phosphate, Dibasic, Anhydrous
  • Cellulose, Microcrystalline
  • Starch, Corn
  • Meglumine
  • Croscarmellose Sodium
  • Povidones
  • Poloxamer 181
  • Magnesium Stearate
  • Silicon Dioxide
  • Ferric Oxide Yellow

Pharmaceutical Classes:

  • Glinide [EPC]
  • Potassium Channel Antagonists [MoA]

Related Products:

Based on records with the same trade name.
  • 57664-747 Repaglinide 2 mg Oral Tablet by Caraco Pharmaceutical Laboratories, Ltd.
  • 0378-3121 Repaglinide 0.5 mg Oral Tablet by Mylan Pharmaceuticals Inc.
  • 0378-3122 Repaglinide 1 mg/1 Oral Tablet by Mylan Pharmaceuticals Inc.
  • 0378-3123 Repaglinide 2 mg/1 Oral Tablet by Mylan Pharmaceuticals Inc.
  • 0574-0240 Repaglinide 0.5 mg Oral Tablet by Paddock Laboratories, LLC
  • 0574-0241 Repaglinide 1 mg/1 Oral Tablet by Paddock Laboratories, LLC
  • 0574-0242 Repaglinide 2 mg/1 Oral Tablet by Paddock Laboratories, LLC
  • 0781-5148 Repaglinide .5 mg/1 Oral Tablet by Sandoz Inc
  • 0781-5149 Repaglinide 1 mg/1 Oral Tablet by Sandoz Inc
  • 0781-5150 Repaglinide 2 mg/1 Oral Tablet by Sandoz Inc
  • 33342-248 Repaglinide .5 mg Oral Tablet by Macleods Pharmaceuticals Limited
  • 33342-249 Repaglinide 1 mg Oral Tablet by Macleods Pharmaceuticals Limited
  • 33342-250 Repaglinide 2 mg Oral Tablet by Macleods Pharmaceuticals Limited
  • 42291-719 Repaglinide 1 mg/1 Oral Tablet by Avkare, Inc.
  • 42291-720 Repaglinide 2 mg/1 Oral Tablet by Avkare, Inc.
  • 51079-062 Repaglinide .5 mg/1 Oral Tablet by Mylan Institutional Inc.
  • 51079-539 Repaglinide 1 mg/1 Oral Tablet by Mylan Institutional Inc.
  • 51079-555 Repaglinide 2 mg/1 Oral Tablet by Mylan Institutional Inc.
  • 51991-853 Repaglinide .5 mg Oral Tablet by Breckenridge Pharmaceutical, Inc.
  • 51991-854 Repaglinide 1 mg Oral Tablet by Breckenridge Pharmaceutical, Inc.
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 57664-745 QR Code

< Prev: 57664-727Next: 57664-747 >

Related Discussions:

Prandimet(metformin and repaglinide
specify availability of Prandimet(metformin and repaglinide) in india....




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.